Human PSA-ACT Complex Native

<strong>Human PSA-ACT Complex Native</strong>_x000D_ <strong>Catalog number:</strong> B2017038_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 10 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20¬∞C_x000D_ <strong>Keywords:</strong> Prostate specific antigen, P-30 antigen, gamma-seminoprotein, kallikrein-related peptidase 3, kallikrein-3, semenogelase, seminin, APS, PSA, hK3, KLK2A1, KLK3_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MŒ©-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Pettersson K, Piironen T, Sepp√§l√§ M, Liukkonen L, Christensson A, Matikainen MT, Suonp√§√§ M, L√∂vgren T, Lilja H. Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex Clin Chem. 1995 Oct;41(10):1480-8._x000D_ 2: Becker C, Wigheden I, Lilja H. Characterization of epitope structure for 53 monoclonal antibodies against prostate-specific antigen Tumour Biol. 1999;20 Suppl 1:13-7._x000D_ 3: Stenman UH, Leinonen J, Zhang WM, Finne P. Prostate-specific antigen Semin Cancer Biol. 1999 Apr;9(2):83-93._x000D_ 4: Wu JT, Zhang P, Bandhauer ME, Wilson L, Astill ME, Colemere JT. Purification of PSA-ACT complex: characterization of PSA-ACT complex by various chromatographic procedures J Clin Lab Anal. 1995;9(1):25-31._x000D_ 5: Stenman UH, Leinonen J, Zhang WM. Standardization of PSA determinations Scand J Clin Lab Invest Suppl. 1995;221:45-51._x000D_ 6: Mulder SD, Heijst JA, Mulder C, Martens F, Hack CE, Scheltens P, Blankenstein MA, Veerhuis R. CSF levels of PSA and PSA-ACT complexes in Alzheimer's disease Ann Clin Biochem. 2009 Nov;46(Pt 6):477-83._x000D_ 7: Wu JT, Zhang P, Liu GH, Wilson L. Development of an immunoassay specific for the PSA-ACT complex without the problem of high background J Clin Lab Anal. 1998;12(1):14-9._x000D_ 8: Wu JT, Wilson LW. Development of a microplate ELISA for free PSA and PSA-ACT complex in serum J Clin Lab Anal. 1995;9(4):252-60._x000D_ 9: Stephan C, Jung K, Brux B, Lein M, Sinha P, Schnorr D, Loening SA. ACT-PSA and complexed PSA elimination kinetics in serum after radical retropubic prostatectomy: proof of new complex forming of PSA after release into circulation Urology. 2000 Apr;55(4):560-3._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/12746838">10: Wan XS, Xu YA, Ware JH, Kennedy AR. Three immunoassays based on monoclonal antibodies specific for prostate specific antigen (PSA), alpha-1-antichymotrypsin (ACT), and the PSA-ACT complex Prostate. 2003 Jul 1;56(2):131-41. </a>_x000D_ _x000D_ <strong>Products Related to Human PSA-ACT Complex Native can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>